Evaluation of the Pharmacokinetics of AG-221, a Potent Mutant IDH2 Inhibitor, in Patients with IDH2-Mutation Positive Advanced Hematologic Malignancies in a Phase 1/2 Trial
暂无分享,去创建一个
Hua Yang | E. Attar | S. Agresta | K. Le | R. Knight | Yan Li | Jian Chen | Qiang Xu | A. Thakurta | A. Tosolini | K. Yen | J. Mei | Erika L. Manyak | Yue Gao | Bin Fan